Targeting HCV Entry For Development of Therapeutics

Por Wong-Staal, Flossie, Syder, Andrew J., McKelvy, Jeffrey F.
Publicado em 2010

Effect of scavenger receptor BI antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation

Por Rowe, Ian A, Tully, Damien C, Armstrong, Matthew J, Parker, Richard, Guo, Kathy, Barton, Darren, Morse, Gene D, Venuto, Charles S, Ogilvie, Colin B, Hedegaard, Ditte L, McKelvy, Jeffrey F, Wong-Staal, Flossie, Allen, Todd M, Balfe, Peter, McKeating, Jane A, Mutimer., David J
Publicado no Liver Transpl (2016)